Omnicare and McKesson to extend drug distribution deal
By
Elizabeth Newman
Jan 01, 2015
Omnicare Inc. and McKesson Corporation have decided to extend their agreement through 2019, which will include the sourcing and distribution of branded, specialty and generic pharmaceuticals.
FDA wants lower doses for sleeping aids
By
Elizabeth Newman
Feb 01, 2013
The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.
FDA agrees to deal that speeds reviews
By
Matthew Arnold
Oct 01, 2011
The Food and Drug Administration and the biopharma industry have agreed in principle on a revamp of the Prescription Drug User Fee Act, by which drug firms provide nearly two-thirds of what the agency...
Pfizer mulls possible OTC Lipitor switch
By
Matthew Arnold
Sep 01, 2011
Pfizer is reportedly weighing an attempt at an over-the-counter switch for Lipitor — a move that could help the company recoup some of its losses when the $11 billion drug loses nationwide exclusivity...
Logo color affects buyer perceptions
By
Elizabeth Newman
May 01, 2014
The combination of blue, yellow or red logos for many long-term care companies may not be an accident, according to new study results from the University of Missouri.
Omnicare extends PharMerica buy offer
By
John O'Connor
Jan 03, 2012
Pharmacy giant Omnicare announced that it was extending to Jan. 20 its offer to purchase all outstanding shares of rival PharMerica for $15 per share. The original offer had been scheduled to expire in...
Dementia drug dosage comes under fire
By
Deborah Weinstein
May 01, 2012
The Food and Drug Administration “breached its own regulatory standard” when it permitted a new dosage for a best-selling Alzheimer’s drug, according to two professors at Dartmouth’s...